Interaction of thioridazine with ocular melanin in vitro

Acta Poloniae Pharmaceutica - Drug Research

Volumn 60, Issue 4, 2003, Pages 257-261

  Buszman, Ewa ^a   Rózańska, Renata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Drug melanin interaction; Ocular toxicity; Thioridazine

Indexed keywords

DOPA; MELANIN; NEUROLEPTIC AGENT; THIORIDAZINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG CROSS REACTIVITY; DRUG PROTEIN BINDING; DRUG STABILITY; EQUILIBRIUM CONSTANT; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PIGMENT DISORDER; PIGMENT EPITHELIUM; PROTEIN ISOLATION; RETINOPATHY; STATISTICAL SIGNIFICANCE; SWINE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; ANTIPSYCHOTIC AGENTS; DIHYDROXYPHENYLALANINE; EYE; INDICATORS AND REAGENTS; KINETICS; MELANINS; SPECTROPHOTOMETRY, ULTRAVIOLET; SWINE; THERMODYNAMICS; THIORIDAZINE;

EID: 0142074367     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Martindale. The Complete Drug Reference. 32ed., Parfitt K., Ed., p. 695, The Pharmaceutical Press, London 1999.
2. Baldessarini R. J.: in Goodman & Gilman's The Pharmacological Basis of Therapeutics. Ninth Ed., Hardman J. G., Limbird L. E., Molinoff P. B., Ruddon R. W., Gilman A. G. Eds., p. 399, McGraw-Hill, International Edition 1996.
3. Marmor M. F.: Br. J. Ophthalmol. 74, 739 (1990).
4. Rennie I. G.: Drug Safety 9, 196 (1993).
5. Oshika T.: Drug Safety 12, 256 (1995).
6. Shah G. K., Auerbach D. B., Augsburger J. J., Saviano P. J.: Arch. Ophthalmol. 116, 826 (1998).
7. Tekell J. L, Silva J. A., Maas J. A., Bowden C. L., Starck T.: Am. J. Psychiat. 153, 1234 (1996).
8. To T. Q., Townsend J. C.: J. Am. Optom. Assoc. 71, 29 (2000).
9. Anderton L., Bishop P.: Am. J. Psychiat. 158, 5 (2001).
10. Ito S., Wakamatsu K., Ozeki H.: Pigment Cell Res. 13, 103 (2000).
11. Sturm R. A., Teasdale R. D., Box N. F.: Gene 277, 49 (2001).
12. Ortonne J-P.: Br. J. Dermatol. 146 (Suppl.61), 7 (2002).
13. Riley P. A.: Int. J. Biochem. Cell Biol. 29, 1235 (1997).
14. Larsson B. S.: Pigment Cell Res. 6, 127 (1993).
15. Eves P., Smith-Thomas L., Hedley S., Wagner M., Balafa Ch., Mac Neil S.: Pigment Cell Res. 12, 22 (1999).
16. Koneru P. B., Lien E. J., Koa R. T.: J. Ocul. Pharmacol. 2, 385 (1986).
17. Leblanc B., Jezequel S., Davies T., Hanton G., Taradach C.: Regul. Toxicol. Pharm. 28, 124 (1998).
18. Buszman E.: Binding of Drugs to Melanin Biopolymers in the Presence of Metal Ions. D. Sc. Thesis Medical University of Silesia, Katowice 1994.
19. Wrześniok D., Buszman E., Karna E., Nawrat P., Pałka J.: Eur. J. Pharmacol. 446, 7 (2002).
20. Binns F., Chapman R. F., Robson N. C., Swan G. A., Waggott A.: J. Chem. Soc. (C) 1128 (1970).
21. Persad S., Menon J. A., Basu P. K., Haberman H. F.: J. Toxicol.-Cut. Ocular Toxicol. 5, 125 (1986).
22. Kalbitzer H. R., Stehlik D.: Z. Naturforsch. C. 34, 757 (1979).